Avanir Pharmaceuticals to Participate in Two Investor Conferences

ALISO VIEJO, Calif., Sept. 15, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will participate in two upcoming investment conferences.

The conference schedule is as follows:

  • UBS Global Life Sciences Conference
    • Grand Hyatt, New York, NY
    • Tuesday September 20, 2011
    • 11:30 a.m. ET

  • Sixth Annual JMP Securities Healthcare Conference
    • St. Regis, New York, NY
    • Tuesday September 27, 2011
    • 9:00 a.m. ET

A live webcast and 30-day archive of these presentations will be available at http://www.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR™ is a trademark owned by Avanir Pharmaceuticals, Inc.

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.

SOURCE Avanir Pharmaceuticals, Inc.

Sep 15, 2011